<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 26, 1999
DURAMED PHARMACEUTICALS, INC.
______________________________________________________
(Exact name of registrant as specified in its charter)
Delaware 0-15242 11-2590026
__________________________________________________________
(State or other (Commission (IRS Employer
Jurisdiction of File Number) Identification
incorporation) No.)
7155 East Kemper Road, Cincinnati, Ohio 45249 (513) 731-9900
________________________________________________________________
(Address and telephone number, including area code, of principal
executive offices)
<PAGE>
INFORMATION TO BE INCLUDED IN THE REPORT
Items 1, 2, 3, 4, 6, 7, 8 and 9 are not applicable and are omitted
from this Report.
Item 5. Other Events
____________
The 1999 Annual Meeting of Stockholders of Duramed
Pharmaceuticals, Inc. will be held on June 24, 1999.
Any stockholder desiring to submit a proposal under
Securities and Exchange Commission Rule 14a-4(c) for
consideration at the 1999 Annual Meeting must notify
Duramed prior to April 26, 1999. The March 31, 1999
deadline for stockholder proposals under SEC Rule 14a-8
(set forth in Duramed's Proxy Statement for its 1998
Annual Meeting) remains unchanged.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
Date: March 26, 1999 DURAMED PHARMACEUTICALS, INC.
By /s/ Timothy J. Holt
_________________________________
Timothy J. Holt
Senior Vice President-Finance and
Administration
